Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
EX ›
EXCLUDIF
Trademark search for:
EXCLUDIF
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-12-18 — Application filed
2019-12-21 — Application filed
2019-12-21 — Application filed
2020-03-17 — Final disposition recorded
2020-03-17 — Final disposition recorded
2020-03-17 — Assigned to examiner
2020-03-17 — Final disposition recorded
2020-09-16 — Teas/email correspondence entered
2020-09-16 — Office action issued
2020-09-16 — Correspondence received in law office
2020-09-17 — Approved for pub - principal register
2020-10-07 — Notification of notice of publication e-mailed
2020-10-27 — Published for opposition
2020-10-27 — Official gazette publication confirmation e-mailed
2020-12-22 — Noa e-mailed - sou required from applicant
2021-06-10 — Sou teas extension received
2021-06-10 — Sou extension 1 filed
2021-06-10 — Sou extension 1 granted
2021-06-12 — Notice of approval of extension request e-mailed
2021-12-08 — Sou teas extension received
2021-12-08 — Sou extension 2 filed
2021-12-08 — Sou extension 2 granted
2021-12-10 — Notice of approval of extension request e-mailed
2022-07-25 — Application abandoned
2022-07-25 — Application abandoned
2022-07-25 — Final status recorded
Owner Information
Seres Therapeutics, Inc.
Seres Therapeutics, Inc.
Correspondent
Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
